{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:46:38Z","timestamp":1790279198337,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014895","name":"Southwest Medical University","doi-asserted-by":"publisher","award":["334076"],"award-info":[{"award-number":["334076"]}],"id":[{"id":"10.13039\/501100014895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014895","name":"Southwest Medical University","doi-asserted-by":"publisher","award":["2024LZXNYDJ064"],"award-info":[{"award-number":["2024LZXNYDJ064"]}],"id":[{"id":"10.13039\/501100014895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2025ZNSFSC1527"],"award-info":[{"award-number":["2025ZNSFSC1527"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403915"],"award-info":[{"award-number":["82403915"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015375","name":"Affiliated Hospital of Southwest Medical University","doi-asserted-by":"publisher","award":["24075"],"award-info":[{"award-number":["24075"]}],"id":[{"id":"10.13039\/501100015375","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.intimp.2026.117229","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:50:20Z","timestamp":1786377020000},"page":"117229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The G-quadruplex ligand CX-5461 inhibits laryngeal cancer via inducing immunogenic cell death and remodeling the tumor immune microenvironment"],"prefix":"10.1016","volume":"187","author":[{"given":"Fang-Yuan","family":"Teng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.117229_bb0005","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.molmed.2020.05.002","article-title":"G-quadruplex, friend or foe: the role of the G-quartet in anticancer strategies","volume":"26","author":"Carvalho","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.intimp.2026.117229_bb0010","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41580-020-0236-x","article-title":"The regulation and functions of DNA and RNA G-quadruplexes","volume":"21","author":"Varshney","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2026.117229_bb0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s11658-026-00890-3","article-title":"G-quadruplex stabilization via small molecules as a potential anti-cancer strategy","volume":"31","author":"Li","year":"2026","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.intimp.2026.117229_bb0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.tig.2022.10.006","article-title":"Mitochondria and G-quadruplex evolution: an intertwined relationship","volume":"39","author":"Sahayasheela","year":"2023","journal-title":"Trends Genet."},{"key":"10.1016\/j.intimp.2026.117229_bb0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41419-023-05562-0","article-title":"Crosstalk between G-quadruplex and ROS","volume":"14","author":"Wu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.117229_bb0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.tig.2018.11.001","article-title":"Non-duplex G-quadruplex structures emerge as mediators of epigenetic modifications","volume":"35","author":"Mukherjee","year":"2019","journal-title":"Trends in genetics\u202f: TIG"},{"key":"10.1016\/j.intimp.2026.117229_bb0035","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.tibs.2023.06.007","article-title":"Advances and challenges in identifying and characterizing G-quadruplex-protein interactions","volume":"48","author":"Dai","year":"2023","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.intimp.2026.117229_bb0040","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41588-020-0672-8","article-title":"Landscape of G-quadruplex DNA structural regions in breast cancer","volume":"52","author":"Hansel-Hertsch","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2026.117229_bb0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00018-023-05046-6","article-title":"G-quadruplex structural dynamics at MAPK12 promoter dictates transcriptional switch to determine stemness in breast cancer","volume":"81","author":"Sengupta","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2026.117229_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109150","article-title":"Exploration of chromenone-based ligands as DNA G-quadruplex targets in triple-negative breast cancer","volume":"166","author":"Mock","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.intimp.2026.117229_bb0055","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1021\/acs.jmedchem.5c02600","article-title":"Novel Tetrahydroxanthylium-based ligands targeting mitochondrial DNA G-quadruplex structures for concurrent induction of apoptosis and inhibition of autophagy in liver Cancer","volume":"69","author":"Wang","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2026.117229_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2021.119968","article-title":"An increase in DNA G-quadruplex formation in acute myelocytic leukemia is detected by a supramolecular probe","volume":"260","author":"Chen","year":"2021","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.intimp.2026.117229_bb0065","doi-asserted-by":"crossref","first-page":"gkaf167","DOI":"10.1093\/nar\/gkaf167","article-title":"Formation of multiple G-quadruplexes contributes toward BCR fragility associated with chronic myelogenous leukemia","volume":"53","author":"Sharma","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.intimp.2026.117229_bb0070","doi-asserted-by":"crossref","first-page":"eadj8803","DOI":"10.1126\/sciadv.adj8803","article-title":"ERG and c-MYC regulate a critical gene network in BCR::ABL1-driven B cell acute lymphoblastic leukemia","volume":"10","author":"Behrens","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.intimp.2026.117229_bb0075","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nchem.1126","article-title":"A single-molecule platform for investigation of interactions between G-quadruplexes and small-molecule ligands","volume":"3","author":"Koirala","year":"2011","journal-title":"Nat. Chem."},{"key":"10.1016\/j.intimp.2026.117229_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116277","article-title":"ARID1A stabilizes non-homologous end joining factors at DNA breaks induced by the G4 ligand pyridostatin","volume":"44","author":"Sim\u00f5es-Sousa","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2026.117229_bb0085","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/0008-5472.CAN-10-1728","article-title":"Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth","volume":"71","author":"Drygin","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.117229_bb0090","doi-asserted-by":"crossref","first-page":"gkag667","DOI":"10.1093\/nar\/gkag667","article-title":"Structural insights into the binding of CX-5461 and MTR-106 to G-quadruplex DNA","volume":"54","author":"Li","year":"2026","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.intimp.2026.117229_bb0095","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1158\/0008-5472.CAN-04-2910","article-title":"The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function","volume":"65","author":"Burger","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.117229_bb0100","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1002\/ps.8769","article-title":"BRACO-19 targeted the G-quadruplex in the 3\u2019UTR of the cucumber mosaic virus 1a, 2b, and CP genes to inhibit viral proliferation","volume":"81","author":"Gao","year":"2025","journal-title":"Pest Manag. Sci."},{"key":"10.1016\/j.intimp.2026.117229_bb0105","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1016\/j.bmcl.2006.03.087","article-title":"Spectroscopic studies of the interaction between quercetin and G-quadruplex DNA","volume":"16","author":"Sun","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.intimp.2026.117229_bb0110","doi-asserted-by":"crossref","first-page":"39816","DOI":"10.1021\/acsomega.3c06016","article-title":"Binding of quercetin derivatives toward G-tetrads as studied by the survival yield method","volume":"8","author":"St\u0119\u017cycka","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.intimp.2026.117229_bb0115","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.bmcl.2005.12.001","article-title":"Natural and synthetic G-quadruplex interactive berberine derivatives","volume":"16","author":"Franceschin","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.intimp.2026.117229_bb0120","first-page":"237","article-title":"Structural basis of the major TMPRSS2 promoter G-quadruplex and its complex with berberine","volume":"24","author":"Tang","year":"2026","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.intimp.2026.117229_bb0125","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/acssensors.2c00992","article-title":"Recent developments in G-quadruplex binding ligands and specific beacons on smart fluorescent sensor for targeting metal ions and biological analytes","volume":"7","author":"Zhao","year":"2022","journal-title":"ACS Sens."},{"key":"10.1016\/j.intimp.2026.117229_bb0130","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3390\/biom16060835","article-title":"Noble metal complexes and non-canonical nucleic acids: from G-quadruplex recognition to emerging functional architectures","volume":"16","author":"Cirri","year":"2026","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2026.117229_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.129016","article-title":"A first-in-class clinical G-quadruplex-targeting drug. The bench-to-bedside translation of the fluoroquinolone QQ58 to CX-5461 (Pidnarulex)","volume":"77","author":"Xu","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.intimp.2026.117229_bb0140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/s12967-025-06473-8","article-title":"The G-quadruplex ligand CX-5461: an innovative candidate for disease treatment","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2026.117229_bb0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ccr.2012.05.019","article-title":"Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53","volume":"22","author":"Bywater","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.117229_bb0150","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1158\/2159-8290.CD-14-0673","article-title":"Combination therapy targeting ribosome biogenesis and mRNA translation synergistically extends survival in MYC-driven lymphoma","volume":"6","author":"Devlin","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2026.117229_bb0170","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1182\/blood-2016-05-718171","article-title":"Inhibition of pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population","volume":"129","author":"Hein","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.117229_bb0155","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1073\/pnas.1921649117","article-title":"The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoning","volume":"117","author":"Bruno","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.117229_bb0160","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.65184","article-title":"Transcription-associated topoisomerase 2alpha (TOP2A) activity is a major effector of cytotoxicity induced by G-quadruplex ligands","volume":"10","author":"Bossaert","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.intimp.2026.117229_bb0165","article-title":"CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1\/2 deficient tumours","volume":"8","author":"Xu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117229_bb0175","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41419-024-07215-2","article-title":"Targeting G-quadruplex by TMPyP4 for inhibition of colorectal cancer through cell cycle arrest and boosting anti-tumor immunity","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.117229_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100856","article-title":"A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer","volume":"35","author":"Chung","year":"2023","journal-title":"Neoplasia"},{"key":"10.1016\/j.intimp.2026.117229_bb0185","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1093\/nar\/gkab500","article-title":"G-quadruplex binders as cytostatic modulators of innate immune genes in cancer cells","volume":"49","author":"Miglietta","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2026.117229_bb0240","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.3390\/cancers13205056","article-title":"CX-5461 treatment leads to cytosolic DNA-mediated STING activation in ovarian cancer","volume":"13","author":"Cornelison","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.intimp.2026.117229_bb0190","article-title":"Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.intimp.2026.117229_bb0195","first-page":"31","article-title":"An update on larynx cancer","volume":"67","author":"Steuer","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.intimp.2026.117229_bb0200","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.3390\/cancers15205096","article-title":"Biomarkers in laryngeal squamous cell carcinoma: the literature review","volume":"15","author":"Verro","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.intimp.2026.117229_bb0205","article-title":"Construction of CpG delivery nanoplatforms by functionalized MoS(2) nanosheets for boosting antitumor immunity in head and neck squamous cell carcinoma","volume":"19","author":"Li","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.intimp.2026.117229_bb0210","doi-asserted-by":"crossref","first-page":"6557","DOI":"10.1007\/s00018-021-03921-8","article-title":"G-quadruplex DNA: a novel target for drug design","volume":"78","author":"Teng","year":"2021","journal-title":"Cellular and molecular life sciences : CMLS"},{"key":"10.1016\/j.intimp.2026.117229_bb0215","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1158\/2159-8290.CD-18-1455","article-title":"First-in-human RNA polymerase I transcription inhibitor CX-5461 in patients with advanced hematologic cancers: results of a phase I dose-escalation study","volume":"9","author":"Khot","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2026.117229_bb0220","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1021\/ml300110s","article-title":"Discovery of CX-5461, the first direct and selective inhibitor of RNA polymerase I, for Cancer therapeutics","volume":"3","author":"Haddach","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.intimp.2026.117229_bb0225","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114501","article-title":"Anti-tumoural activity of the G-quadruplex ligand pyridostatin against BRCA1\/2-deficient tumours","volume":"14","author":"Groelly","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.intimp.2026.117229_bb0230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s11658-025-00839-y","article-title":"G-quadruplex structures are key regulators of mammalian spermatogenesis","volume":"31","author":"Li","year":"2026","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.intimp.2026.117229_bb0235","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2506939122","article-title":"G-quadruplex stabilization induces DNA breaks in pericentromeric repetitive DNA sequences in B lymphocytes","volume":"122","author":"Waisertreiger","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.117229_bb0245","article-title":"Organic-platinum hybrids for covalent binding of G-quadruplexes: structural basis and application to Cancer immunotherapy","volume":"62","author":"Liu","year":"2023","journal-title":"Angew. Chem."},{"key":"10.1016\/j.intimp.2026.117229_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107314","article-title":"Tetrandrine activates STING\/TBK1\/IRF3 pathway to potentiate anti-PD-1 immunotherapy efficacy in non-small cell lung cancer","volume":"207","author":"Tan","year":"2024","journal-title":"Pharmacological research : the official journal of the Italian Pharmacological Society"},{"key":"10.1016\/j.intimp.2026.117229_bb0255","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1093\/nar\/gkae098","article-title":"G-quadruplex-mediated genomic instability drives SNVs in cancer","volume":"52","author":"Richl","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2026.117229_bb0260","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-021-01328-4","article-title":"G-quadruplexes: a promising target for cancer therapy","volume":"20","author":"Kosiol","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2026.117229_bb0265","doi-asserted-by":"crossref","first-page":"1805256","DOI":"10.1080\/23723556.2020.1805256","article-title":"CX-5461 can destabilize replication forks in PARP inhibitor-resistant models of ovarian cancer","volume":"7","author":"Xuan","year":"2020","journal-title":"Mol. Cell. Oncol."},{"key":"10.1016\/j.intimp.2026.117229_bb0270","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1038\/s41467-020-16393-4","article-title":"CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer","volume":"11","author":"Sanij","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2026.117229_bb0275","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41416-020-01158-z","article-title":"The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancer","volume":"124","author":"Yan","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.intimp.2026.117229_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106120","article-title":"CX-5461 is a potent immunosuppressant which inhibits T cell-mediated alloimmunity via p53-DUSP5","volume":"177","author":"Pan","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2026.117229_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2026.117229_bb0290","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.canlet.2016.01.043","article-title":"Tumor microenvironment and therapeutic response","volume":"387","author":"Wu","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2026.117229_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2026.124320","article-title":"Modularly designed hybrid vesicles as dual-adjuvant nanovaccines for cancer immunotherapy","volume":"335","author":"Pan","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2026.117229_bb0300","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202400068","article-title":"Genetically engineered cytomembrane nanovaccines for cancer immunotherapy","volume":"13","author":"Pan","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.intimp.2026.117229_bb0305","first-page":"31","article-title":"Genetically engineered nanomodulators elicit potent immunity against cancer stem cells by checkpoint blockade and hypoxia relief","volume":"38","author":"Pan","year":"2024","journal-title":"Bioact. Mater."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926010751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926010751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:06:48Z","timestamp":1789142808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926010751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":61,"alternative-id":["S1567576926010751"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117229","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The G-quadruplex ligand CX-5461 inhibits laryngeal cancer via inducing immunogenic cell death and remodeling the tumor immune microenvironment","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117229"}}